Department of Pathology and Comprehensive Cancer Center, The University of Michigan Medical School, Ann Arbor, MI, USA.
Immunol Rev. 2017 Sep;279(1):70-89. doi: 10.1111/imr.12567.
The intestinal tract of mammals is colonized by a large number of microorganisms including trillions of bacteria that are referred to collectively as the gut microbiota. These indigenous microorganisms have co-evolved with the host in a symbiotic relationship. In addition to metabolic benefits, symbiotic bacteria provide the host with several functions that promote immune homeostasis, immune responses, and protection against pathogen colonization. The ability of symbiotic bacteria to inhibit pathogen colonization is mediated via several mechanisms including direct killing, competition for limited nutrients, and enhancement of immune responses. Pathogens have evolved strategies to promote their replication in the presence of the gut microbiota. Perturbation of the gut microbiota structure by environmental and genetic factors increases the risk of pathogen infection, promotes the overgrowth of harmful pathobionts, and the development of inflammatory disease. Understanding the interaction of the microbiota with pathogens and the immune system will provide critical insight into the pathogenesis of disease and the development of strategies to prevent and treat inflammatory disease.
哺乳动物的肠道中定植着大量的微生物,包括数以万亿计的细菌,这些微生物被统称为肠道微生物群。这些土著微生物与宿主在共生关系中共同进化。除了代谢益处之外,共生细菌还为宿主提供了多种功能,促进免疫稳态、免疫反应和防止病原体定植。共生细菌抑制病原体定植的能力是通过几种机制介导的,包括直接杀伤、有限营养物质的竞争以及增强免疫反应。病原体已经进化出了在肠道微生物群存在的情况下促进自身复制的策略。环境和遗传因素对肠道微生物群结构的干扰会增加病原体感染的风险、促进有害共生菌的过度生长以及炎症性疾病的发展。了解微生物群与病原体和免疫系统的相互作用将为炎症性疾病的发病机制和预防及治疗炎症性疾病的策略的发展提供重要的见解。
Nat Rev Immunol. 2013-5
Nat Rev Immunol. 2020-1-31
Curr Opin Rheumatol. 2015-7
BMC Immunol. 2017-1-6
J Immunol Res. 2015-2-22
Nihon Rinsho Meneki Gakkai Kaishi. 2017
Exp Mol Med. 2017-5-26
Front Cell Infect Microbiol. 2025-8-21
Front Microbiol. 2025-8-8
Science. 2017-3-16
Immune Netw. 2017-2
Proc Natl Acad Sci U S A. 2016-11-29